Smart companies spend better, not more. Use data to target the right people and focus on lifetime value. Micro-influencers ...

The FDA declined to approve SYD-101, a low-dose atropine formulation that would have been the first pharmaceutical treatment ...

The Food and Drug Administration granted fast track designation to HDP-101 for the treatment of multiple myeloma. The U.S.

Select Wall Street analysts think these artificial intelligence stocks could double your money in the next year.

The COMPARE trial is an open-label, randomized, controlled Phase 1/2 study evaluating KYV-101 against the anti-CD20 monoclonal antibody rituximab in patients with anti-citrullinated protein antibody ...

Discover smart robotics investment strategies—focus on semiconductors, sensors, and software for long-term gains. Click for ...

Layoffs at Jefferson/LVHN? Anyone who didn’t see this coming wasn’t paying attention. It was published that Jefferson was ...

Recognizes the potential of HDP-101 to address a serious or life-threatening condition with high unmet medical needs·           Enables more frequent engagement with FDA ...

Grassley, opposed to Trump proposal to import Argentina beef, says president 'better off' if he stopped tweeting, 'kept his ...

Throughout the last three months, 4 analysts have evaluated TransUnion (NYSE: TRU ), offering a diverse set of opinions from ...

Inhibrx Biosciences, Inc. reports strong phase 2 results for ozekibart in chondrosarcoma, with new cancer data and key ...

The all-time winningest World Cup ski racer and two-time Olympic champion Mikaela Shiffrin is launching a podcast next week.